BackgroundFalsified medicines and their international regulation impacts all healthcare sectors and their actors. These regulations aim to strengthen and protect the global pharmaceutical supply chain against falsified medicines. However. an evaluation of the impacts of these regulations on key stakeholders within the legitimate supply chain have not been explored. https://www.markymarkscott.com/product-category/10v/